Reynolds PN - Search Results

1

The flt-1 promoter for transcriptional targeting of teratocarcinoma.

Bauerschmitz GJ, Nettelbeck DM, Kanerva A, Baker AH, Hemminki A, Reynolds PN, Curiel DT. Bauerschmitz GJ, et al. Among authors: reynolds pn. Cancer Res. 2002 Mar 1;62(5):1271-4. Cancer Res. 2002. PMID: 11888889

2

A new targeting approach for breast cancer gene therapy using the heparanase promoter.

Breidenbach M, Rein DT, Schöndorf T, Khan KN, Herrmann I, Schmidt T, Reynolds PN, Vlodavsky I, Haviv YS, Curiel DT. Breidenbach M, et al. Among authors: reynolds pn. Cancer Lett. 2006 Aug 18;240(1):114-22. doi: 10.1016/j.canlet.2005.09.007. Epub 2005 Nov 3. Cancer Lett. 2006. PMID: 16271435

3

Differential susceptibility of primary and established human glioma cells to adenovirus infection: targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer.

Miller CR, Buchsbaum DJ, Reynolds PN, Douglas JT, Gillespie GY, Mayo MS, Raben D, Curiel DT. Miller CR, et al. Among authors: reynolds pn. Cancer Res. 1998 Dec 15;58(24):5738-48. Cancer Res. 1998. PMID: 9865732

4

Midkine promoter-based adenoviral vector gene delivery for pediatric solid tumors.

Adachi Y, Reynolds PN, Yamamoto M, Grizzle WE, Overturf K, Matsubara S, Muramatsu T, Curiel DT. Adachi Y, et al. Among authors: reynolds pn. Cancer Res. 2000 Aug 15;60(16):4305-10. Cancer Res. 2000. PMID: 10969765

5

A midkine promoter-based conditionally replicative adenovirus for treatment of pediatric solid tumors and bone marrow tumor purging.

Adachi Y, Reynolds PN, Yamamoto M, Wang M, Takayama K, Matsubara S, Muramatsu T, Curiel DT. Adachi Y, et al. Among authors: reynolds pn. Cancer Res. 2001 Nov 1;61(21):7882-8. Cancer Res. 2001. PMID: 11691808

6

Vascular endothelial growth factor promoter-based conditionally replicative adenoviruses for pan-carcinoma application.

Takayama K, Reynolds PN, Adachi Y, Kaliberova L, Uchino J, Nakanishi Y, Curiel DT. Takayama K, et al. Among authors: reynolds pn. Cancer Gene Ther. 2007 Jan;14(1):105-16. doi: 10.1038/sj.cgt.7700991. Epub 2006 Oct 6. Cancer Gene Ther. 2007. PMID: 17024232 Free PMC article.

7

New generation adenoviral vectors improve gene transfer by coxsackie and adenoviral receptor-independent cell entry.

Reynolds PN, Curiel DT. Reynolds PN, et al. Kidney Int. 2002 Jan;61(1 Suppl):S24-31. doi: 10.1046/j.1523-1755.2002.0610s1024.x. Kidney Int. 2002. PMID: 11841608 Free article. Review.

8

Midkine promoter-based adenoviral suicide gene therapy to midkine-positive pediatric tumor.

Adachi Y, Matsubara S, Muramatsu T, Curiel DT, Reynolds PN. Adachi Y, et al. Among authors: reynolds pn. J Pediatr Surg. 2002 Apr;37(4):588-92. doi: 10.1053/jpsu.2002.31615. J Pediatr Surg. 2002. PMID: 11912516

9

Transductional and transcriptional targeting of cancer cells using genetically engineered viral vectors.

Nicklin SA, Dishart KL, Buening H, Reynolds PN, Hallek M, Nemerow GR, Von Seggern DJ, Baker AH. Nicklin SA, et al. Among authors: reynolds pn. Cancer Lett. 2003 Nov 25;201(2):165-73. doi: 10.1016/j.canlet.2003.07.003. Cancer Lett. 2003. PMID: 14607330

10

Promoter-controlled infectivity-enhanced conditionally replicative adenoviral vectors for the treatment of gastric cancer.

Ono HA, Davydova JG, Adachi Y, Takayama K, Barker SD, Reynolds PN, Krasnykh VN, Kunisaki C, Shimada H, Curiel DT, Yamamoto M. Ono HA, et al. Among authors: reynolds pn. J Gastroenterol. 2005 Jan;40(1):31-42. doi: 10.1007/s00535-004-1490-y. J Gastroenterol. 2005. PMID: 15692787

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

170 results

Search Page

Filters